| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Outline of Final Research Achievements |
Cerebrospinal fluid (CSF) levels of microtubule-associated protein 2 (MAP2) were higher in the patients with SSPE, compared with control group, but not serum levels. In addition, CSF quinolinic acid (QA) levels were increased in the patients with SSPE. Our results show that there may be relationships between CSF MAP2 or QA levels and conditions of SSPE. They may be involved in the pathophysiology of SSPE, and they may be candidates as biomarkers of SSPE.
|
